Skip to main content

Latest SEC Filings — Page 190

Page 190 · 30 filings scored 7+ · newest 7:24 AM ET · How scores work

Thu, Aug 1330 filings
9AMBPArdagh Metal Packaging S.A.Controlling Shareholder Ardagh Holdings Initiates Potential Sale of Ardagh Metal PackagingForm 6-K · Current report▲ PositivePro8LGNLegence Corp.Legence Q2 Revenue Doubles to $1.26B; Raises Full-Year GuidanceForm 8-K · Current report▲ PositivePro8IRDMIridium Communications Inc.Rocket Lab Clears HSR, Files S-4 and FCC Applications for Iridium AcquisitionForm 425 · Proxy▲ PositivePro7PBLSParabilis Medicines, Inc.Parabilis Posts Q2 Loss of $2.32/Share, $1.1B Cash, and Regeneron Collaboration DetailsForm 8-K · Current report● Neutral8AVAIAVAI BIO, INC.AVAI Bio Posts $552K Quarterly Loss, Cash Rises to $84K, Going Concern LingersForm 10-Q · Periodic report▼ NegativePro9TSATTelesat CorpTelesat Q2 Loss Widens to $559M on Warrant Fair-Value Hit; Signs $2.7B Arctic Defence ContractForm 6-K · Current report▼ NegativePro7SPIRSpire Global, Inc.Spire Global Reports Q2 Loss, Declining Revenue, Secures $65.4M Private Placement, and Details Arbitration WinForm 10-Q · Periodic report● Neutral7MHMcGraw Hill, Inc.McGraw Hill Q1 FY2027: Net Income Jumps to $57.9M, Revenue Up 2.6%Form 10-Q · Periodic report▲ Positive7MHMcGraw Hill, Inc.McGraw Hill Q1 FY2027: Net Income Soars to $57.9M, Guidance ReaffirmedForm 8-K · Current report▲ Positive8ZBIOZenas BioPharma, Inc.Zenas BioPharma Q2 2026: $673.9M Cash, FDA BLA Accepted, CFO TransitionForm 10-Q · Periodic report▲ PositivePro8CLBTCellebrite DI Ltd.Cellebrite Appoints Shiven Ramji as CEO and Lowers FY26 ARR and Revenue OutlookForm 6-K · Current report▼ NegativePro7PHIPLDT Inc.PLDT Reports Flat Core Income, Declares Php46 DividendForm 6-K · Current report● Neutral7ALHAlliance Laundry Holdings Inc.Alliance Laundry Q2 Earnings: Net Income Up 121%, Raises Full-Year EBITDA GuidanceForm 8-K · Current report▲ Positive7RKLBRocket Lab CorpRocket Lab Replaces ATM Program with $1.94B Unsold Amount, Adds Forward Sales; Iridium Deal AdvancesForm 8-K · Current report● Neutral7LNSRLENSAR, Inc.LENSAR Q2 Revenue Up 18%, Swings to Profit on Strong ALLY AdoptionForm 8-K · Current report▲ Positive8FRMIFermi Inc.Fermi Reports Q2 Results, Signs $6.5B TensorWave Deal, and Raises $431M in Convertible NotesForm 8-K · Current report▲ PositivePro7MWHSOLV Energy, Inc.SOLV Energy Q2 Revenue Jumps 77% to $951M; Raises Full-Year GuidanceForm 8-K · Current report▲ Positive7CWBHFCharlotte's Web Holdings, Inc.Charlotte's Web Q2 2026: BAT Conversion Cleans Balance Sheet, But Revenue Slides 15%Form 10-Q · Periodic report● Neutral7CWBHFCharlotte's Web Holdings, Inc.Charlotte's Web Q2: Balance Sheet Restored, Hemp Policy Momentum BuildsForm 8-K · Current report▲ Positive8BSPBending Spoons S.p.A.Bending Spoons Q2 Revenue Jumps 126% to $704M; Guides FY26 Revenue to $2.8BForm 6-K · Current report▲ PositivePro7EVGNEvogene Ltd.Director Leon Recanati Buys $292K of Evogene Shares Amid Activist FightSchedule 13D/A · Ownership stake▲ Positive8ZBIOZenas BioPharma, Inc.Zenas BioPharma: FDA Accepts Obexelimab BLA, CFO Transition, Q2 Loss WidensForm 8-K · Current report● NeutralPro7MDWDMediWound Ltd.MediWound Q2 Revenue Misses, Cash Burn Accelerates; Guidance ReaffirmedForm 6-K · Current report▼ Negative8SGMTSagimet Biosciences Inc.FDA Greenlights Phase 3 Trial of Denifanstat for Moderate to Severe AcneForm 8-K · Current report▲ PositivePro7LIENChicago Atlantic BDC, Inc.Chicago Atlantic BDC Reports Q2 NII of $0.34/Share, NAV $13.26; Declares $0.34 DividendForm 8-K · Current report● Neutral9TSATTelesat CorpTelesat Q2: Going Concern Doubt, $709M Loss, and Material WeaknessForm 6-K · Current report▼ NegativePro8SBCSBC Medical Group Holdings IncStrong Q2 Earnings Can't Mask Nasdaq Non-Compliance and Persistent Control Weaknesses at SBC MedicalForm 10-Q · Periodic report▼ NegativePro8CLRBCellectar Biosciences, Inc.Cellectar Reports Q2 Loss, $34M Cash, and Going Concern DoubtForm 10-Q · Periodic report▼ NegativePro7AVAHAveanna Healthcare Holdings, Inc.Aveanna Q2 2026: Revenue Up 13.7%, Net Income $40.3M, Family First Acquisition ClosedForm 10-Q · Periodic report▲ Positive8VREOFVireo Growth Inc.Vireo Growth Secures $85M Revolving Credit Facility, Completes $48.7M PharmaCann AcquisitionForm 8-K · Current report▲ PositivePro
How Wiseek picks and scores these

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.